IIM
Ironwood Investment Management Portfolio holdings
AUM
$206M
This Quarter Return
-3.3%
1 Year Return
+21.74%
3 Year Return
+140.06%
5 Year Return
+272.77%
10 Year Return
+756.46%
AUM
$164M
AUM Growth
+$164M
(-5.6%)
Cap. Flow
+$374K
Cap. Flow
% of AUM
0.23%
Top 10 Holdings %
Top 10 Hldgs %
29.37%
Holding
171
New
4
Increased
26
Reduced
89
Closed
7
Top Buys
| 1 |
iShares Short Treasury Bond ETF
SHV
|
$2.69M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
$977K |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$795K |
| 4 |
Fortive
FTV
|
$313K |
| 5 |
DURECT Corp
DRRX
|
$304K |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
$2.48M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$308K |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$273K |
| 4 |
Kornit Digital
KRNT
|
$261K |
| 5 |
Quanterix
QTRX
|
$255K |
Sector Composition
| 1 | Technology | 28.23% |
| 2 | Industrials | 12.94% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 10.7% |
| 5 | Financials | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
LivePerson
LPSN
$86M
| $106K | 0.06% |
27,129
+899
| +3% | +$3.5K |
|
152
Ribbon Communications
RBBN
$710M
| $51.6K | 0.03% |
19,258
-637
| -3% | -$1.71K |
|
153
Purple Innovation
PRPL
$118M
| $47.4K | 0.03% |
27,741
-789
| -3% | -$1.35K |
|
154
Kezar Life Sciences
KZR
$28.5M
| $34K | 0.02% |
2,861
-1
| -0% | -$12 |
|
|
TWOU
155
DELISTED
2U, Inc.
TWOU
| $32.1K | 0.02% |
433
-8
| -2% | -$593 |
|
|
SDC
156
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $24.3K | 0.01% |
58,625
-1,745
| -3% | -$724 |
|
|
CKPT
157
DELISTED
Checkpoint Therapeutics
CKPT
| $21.8K | 0.01% |
12,801
-371
| -3% | -$631 |
|
158
Bank of America
BAC
$371B
| – | – |
-7,265
| Closed | -$208K |
|
159
Illumina
ILMN
$15.2B
| – | – |
-1,238
| Closed | -$226K |
|
160
iShares Russell 2000 ETF
IWM
$66.6B
| – | – |
-1,330
| Closed | -$249K |
|
|
161
Kornit Digital
KRNT
$648M
| – | – |
-8,872
| Closed | -$261K |
|
|
162
Quanterix
QTRX
$202M
| – | – |
-11,301
| Closed | -$255K |
|
|
163
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-380
| Closed | -$273K |
|